ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links2 made here, not in the record10 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06495164A Real-life Study toUnderstand the Use andEffects of Palbociclib inUS Patients With BreastCancerPfizeractive not recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSPalbociclibIntervention entry›Nov 3 · Claude Opus 5.5 · ExposureNov 18 · Rule based · ExposureExposureAromatase inhibitorsEntry “Aromatase inhibitor”, read by …›Nov 18 · Rule based · ExposureExposureRibociclibIntervention entry›Nov 3 · Claude Opus 5.5 · ExposureNov 18 · Rule based · ExposureExposureAbemaciclibIntervention entry›Nov 3 · Claude Opus 5.5 · ExposureNov 18 · Rule based · ExposureExposureAnastrozoleMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · ExposureExposureExemestaneMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · ExposureExposure

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Palbociclib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Palbociclib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Exposure
Exposure · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3PalbociclibClaude Opus 5.5ExposureCurrent
Nov 3RibociclibClaude Opus 5.5ExposureCurrent
Nov 3AbemaciclibClaude Opus 5.5ExposureCurrent
Nov 10Anastrozolemade hereClaude Opus 5.5ExposureCurrent
Nov 10Exemestanemade hereClaude Opus 5.5ExposureCurrent
Nov 18PalbociclibRule based · role ruleExposureAgrees
Nov 18Aromatase inhibitorsRule based · role ruleExposureCurrent
Nov 18RibociclibRule based · role ruleExposureAgrees
Nov 18AbemaciclibRule based · role ruleExposureAgrees
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.